The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus

The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus

Débora Moitinho Abram,1 Luis Gustavo Romani Fernandes,1,2 Antônio Celso Saragossa Ramos Filho,2 Patrícia Ucelli Simioni2–4 1Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas, Cidade Universitária Zeferino Vaz, C...

Full description

Bibliographic Details
Main Authors: Abram DM, Fernandes LGR, Ramos Filho ACS, Simioni PU
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Drug Design, Development and Therapy
Subjects:
Diabetes mellitus type 1
clinical trials
dendritic cells
Indomelamine
tryptophan
tolerance
Online Access:https://www.dovepress.com/the-modulation-of-enzyme-indoleamine-23-dioxygenase-from-dendritic-cel-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/the-modulation-of-enzyme-indoleamine-23-dioxygenase-from-dendritic-cel-peer-reviewed-article-DDDT

Similar Items